trimetazidine has been researched along with palmitoylcarnitine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athias, P; Demaison, L; Fantini, E; Grynberg, A; Sentex, E | 1 |
| Bakovic, D; Bulat, C; Cavar, M; Dujic, Z; Fabijanic, D; Karanovic, N; Kraljevic, J; Lavie, CJ; Ljubkovic, M; Marinovic, J; Wisloff, U | 1 |
2 other study(ies) available for trimetazidine and palmitoylcarnitine
| Article | Year |
|---|---|
Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation.
Topics: Adenine Nucleotides; Animals; Cell Hypoxia; Cells, Cultured; Culture Media, Conditioned; Heart; Hydrogen Peroxide; L-Lactate Dehydrogenase; Linolenic Acids; Lipid Peroxides; Membrane Lipids; Mitochondria, Heart; Muscle Proteins; Myocardium; Oxidation-Reduction; Oxygen; Oxygen Consumption; Palmitoylcarnitine; Rats; Rats, Wistar; Trimetazidine | 1994 |
Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.
Topics: Aged; Coronary Artery Disease; Female; Humans; Male; Mitochondria, Heart; Oxidation-Reduction; Palmitoylcarnitine; Pyruvic Acid; Trimetazidine | 2016 |